Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4747446
Max Phase: Preclinical
Molecular Formula: C29H36N2O7
Molecular Weight: 524.61
Molecule Type: Unknown
Associated Items:
ID: ALA4747446
Max Phase: Preclinical
Molecular Formula: C29H36N2O7
Molecular Weight: 524.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1C[C@H]2[C@@H](C=C[C@@H]3[C@H]4C/C=C\C(=O)NCC[C@H](O)[C@@H]5NC(=O)C(=C5O)C(=O)/C=C/[C@@H]4C[C@@H]32)[C@@H]1C(=O)CO
Standard InChI: InChI=1S/C29H36N2O7/c1-14-11-19-18(25(14)23(35)13-32)7-6-17-16-3-2-4-24(36)30-10-9-22(34)27-28(37)26(29(38)31-27)21(33)8-5-15(16)12-20(17)19/h2,4-8,14-20,22,25,27,32,34,37H,3,9-13H2,1H3,(H,30,36)(H,31,38)/b4-2-,8-5+/t14-,15-,16+,17-,18-,19+,20+,22+,25-,27+/m1/s1
Standard InChI Key: HYCXKIREGXDTCK-RQGYKDNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 524.61 | Molecular Weight (Monoisotopic): 524.2523 | AlogP: 1.14 | #Rotatable Bonds: 2 |
Polar Surface Area: 153.03 | Molecular Species: ACID | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.43 | CX Basic pKa: | CX LogP: 0.37 | CX LogD: -3.03 |
Aromatic Rings: 0 | Heavy Atoms: 38 | QED Weighted: 0.27 | Np Likeness Score: 1.64 |
1. Jiao YJ,Liu Y,Wang HX,Zhu DY,Shen YM,Li YY. (2020) Expression of the Clifednamide Biosynthetic Pathway in Streptomyces Generates 27,28-seco-Derivatives., 83 (9.0): [PMID:32915576] [10.1021/acs.jnatprod.0c00900] |
Source(1):